SNL BioSolutions ApS: Financial statements 2024
CVR: 44569272
SNL BioSolutions ApS (CVR 44569272) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,543,476 and a net result of DKK -3,896,480. Equity amounted to DKK -3,850,164. The company had 6 employees in the financial year.
- Gross Profit
- -1,543,476 kr.
- Profit/Loss
- -3,896,480 kr.
- Equity
- -3,850,164 kr.
- Total Assets
- 880,981 kr.
- Employees
- 6
How creditworthy is SNL BioSolutions ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
As of December 3, 2024, Jarne Elleholm has joined the board of directors of SNL BioSolutions ApS.
As of December 3, 2024, Dayanand Suryabhan Jadhav has joined the board of directors of SNL BioSolutions ApS.
As of January 17, 2024, Dayanand Suryabhan Jadhav is registered as director of SNL BioSolutions ApS.
SNL BioSolutions ApS was founded on January 17, 2024.
About SNL BioSolutions ApS
SNL BioSolutions ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Dayanand Suryabhan Jadhav. The company is owned by SNLB Holding ApS. In 2025, the company reported a gross profit of DKK -606,994 and a net result of DKK -1,756,475 compared with DKK -3,896,480 the year before. Equity amounted to DKK -4,706,639.
